News
4h
Zacks Investment Research on MSNWhy Eli Lilly (LLY) is a Top Growth Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
Morgan Stanley identifies 15 stocks with potential near-term catalysts for growth, offering insights on upcoming earnings and ...
Morgan Stanley expects a “normal” earnings beat rate for the second quarter, with S&P 500 EPS growth forecast at 5% year-over-year and sales up 4%.
Markets reflect a widespread belief that the US president always chickens out on trade measures. AstraZeneca’s plan to invest ...
Eli Lilly faces a pivotal moment as its stock experiences a slight pullback. Investors are eyeing its upcoming earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results